Wednesday Nov 25 | Drugs.com
TGaS Advisors Summit: "Best Days are Ahead"
Flexible, scalable commercialization models; the overnight shift from campaign-driven marketing to digital dialogue; Operations support for Managed Markets; and new approaches to incentive compensation and customer data are some of the key challenges for Commercial Operations leaders in 2010, according to participants in a recent TGaS Advisors ...
Spectrum Pharmaceuticals, Inc. Inks Deal with Korea's Handok...
Spectrum Pharmaceuticals, Inc. , a commercial stage biotechnology company with a primary focus in oncology, and Handok Pharmaceuticals Co., Ltd., a fully integrated Korean pharmaceutical company, today announced a collaboration for the development and commercialization of apaziquone in South Korea.
Vanity could help fund health care
They call it the "Botax." The White House and Senate Democrats have turned to a proposal to tax breast implants, tummy tucks, wrinkle-smoothing injections and other procedures as they search for ways to pay for costly health care overhaul plans.
Botax ? Nip/tuck levy to help fund health plan
Dr. Jeffrey M. Kenkel gives patient Amy Andrade a Botox treatment at his office in the Northpark Mall in Dallas, back in 2006.
J&J Axes Evolence, Its "Too Lumpy" Dermal Filler; Allergan, Medicis Rejoice
Kudos to Allergan and Medicis , marketers of Juvederm and Restylane , respectively: The rivals have successfully seen off the much larger J&J, which bought its way into the category in 2008 with the acquisition of Mentor Corp.
British Consul Tries U.S. Healthcare; Execs See Slow RecoveryLoading...
Business Journal October 5 , 2009 - October 11 , 2009 SECTION: Pg. 3 Vol. 32 No.
Qiagen 3Q profit jumps on boost in test sales
Medicis Pharmaceutical Corp. posted a third-quarter profit on Wednesday, as sales of its skin products surged, and a research and development charge came off the books.
Ralcorp nearly doubles profit in 4th-quarter
Ralcorp Holdings Inc. said Tuesday its fiscal fourth-quarter profit nearly doubled on higher sales and a boost from its acquisition of Post Foods.
Prudential posts 3Q profit on market, sales gains
Prudential Financial Inc., an insurance and investment company, posted its second straight quarterly profit, buoyed by market gains and strong sales of its insurance products.
The Lowe Law Firm Files Suit Over Alleged Botox Overdose
St. Louis-based The Lowe Law Firm has filed a lawsuit on behalf of a man who experienced partial respiratory paralysis and other side effects after receiving an overdose of the Botox being used to treat his muscle spasticity.
Northrop sells advisory services unit for $1.65B
Northrop Grumman said Sunday it agreed to sell its advisory services business TASC Inc.
Qualcomm 4Q profit slips 9 percent
Qualcomm Inc. says its fourth-quarter profit slipped 9 percent as revenue from the mobile phone technology it licenses and mobile-phone chips it makes declined.
CVS Caremark 3Q profit jumps 39 percent
CVS Caremark Corp. said Thursday its third-quarter profit jumped 39 percent to more than $1 billion on a boost from pharmacy benefits services and drugstore sales.
TRW shares rise on strong earnings
Shares of TRW Automotive Holdings Corp. rose Thursday, a day after the auto parts supplier reported a third-quarter profit that beat Wall Street predictions and raised its fiscal year projections.
CareFusion profit down, but company lifts outlook
Medical technology company CareFusion Corp. said its profit slid 28 percent in the fiscal first quarter compared to a year ago, when it posted a large gain from discontinued operations.
RothmanResearch.com Completes Analysis on AGN, DAL, SLM, LXP, COG and EPI
On this day, we have begun tracking the following companies as they have shown remarkable correction in recent days, you can access these free reports with a number of other reviews by signing up for your complimentary membership at : http://www.rothmanresearch.com/ Companies been researched today are: Allergan Inc.
Personal Health: News and Notes
In December, the Food and Drug Administration approved Latisse to treat "hypotrichosis," a disease of deficient eyelashes.
Vanguard Healthcare Fund Buys Q3 Portfolio: CEPH, JNJ, ONXX, CBST
If you think to invest in healthcare industry amid the government controlled reform, you may want to look at Edward Owens a TM Vanguard Healthcare Fund portfolio.
GEO Group posts rise in 3Q profit on strong demand
Geo Group Inc., which provides correctional, detention and mental-health services, said Monday its third-quarter earnings jumped 21 percent on strong demand in its markets.
Motorola: Analysts' Upgrades, Downgrades
Estimates were boosted through 2010. Company is seeing lower input costs. Neutral rating and new $60 price target.
Also on Topix